CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-12 | Halpin Michael Chief Operating Officer | Option exercise | +3,500 | 4,449 | ||
| 2024-02-12 | Halpin Michael Chief Operating Officer | Shares withheld for taxes | −1,782 | $47.42 | $85K | 2,667 |
| 2024-02-12 | Halpin Michael Chief Operating Officer | Option exercise · Restricted Stock Unit | +3,500 | 0 | ||
| 2024-02-12 | Colangelo Dominick President and CEO | Option exercise | +7,500 | 177,485 | ||
| 2024-02-12 | Colangelo Dominick President and CEO | Shares withheld for taxes | −3,477 | $47.42 | $165K | 174,008 |
| 2024-02-12 | Colangelo Dominick President and CEO | Option exercise · Restricted Stock Unit | +7,500 | 0 | ||
| 2024-01-29 | ZERBE ROBERT L MD Director | Sale | −2,300 | $44.22 | $102K | 23,395 |
| 2024-01-25 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −200 | $44.02 | $9K | 25,695 |
| 2024-01-22 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −2,500 | $41.39 | $103K | 28,395 |
| 2024-01-22 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −2,500 | $42.06 | $105K | 25,895 |
| 2024-01-22 | ZERBE ROBERT L MD Director | Option exercise 10b5-1 | +3,000 | $4.12 | $12K | 28,895 |
| 2024-01-22 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −3,000 | $42.05 | $126K | 25,895 |
| 2024-01-22 | ZERBE ROBERT L MD Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | +3,000 | 0 | ||
| 2024-01-18 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +16,726 | $3.02 | $51K | 186,711 |
| 2024-01-18 | Colangelo Dominick President and CEO | Sale 10b5-1 | −16,726 | $38.58 | $645K | 169,985 |
| 2024-01-18 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +16,726 | 350,000 | ||
| 2024-01-17 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +16,726 | $3.02 | $51K | 186,711 |
| 2024-01-17 | Colangelo Dominick President and CEO | Sale 10b5-1 | −16,726 | $37.97 | $635K | 169,985 |
| 2024-01-17 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +16,726 | 366,726 | ||
| 2024-01-12 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −2,200 | $38.09 | $84K | 30,895 |
Page 33 of 75 · 1,497 trades